ArticleBMC health services research2025
Effect of a public health protection scheme for the below-poverty-line population on out-of-pocket inpatient care expenditure in Bangladesh: findings from a quasi-experimental study.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIn Bangladesh, households' out-of-pocket (OOP) health expenditure accounts for 68.5% of the total health expenditure. The Government of Bangladesh has been implementing a pilot health protection scheme called Shasthyo Surokhsha Karmasuchi (SSK) to protect the below-poverty-line population from higher financial burdens in accessing inpatient care since 2016. This study aimed to estimate and compare the OOP expenditures between patients enrolled in the SSK scheme and those not enrolled and identify the factors influencing OOP expenditures for inpatient care in Bangladesh.
methodsWe conducted a quasi-experimental study using an exit patient survey in 2021. A predefined standard method was used to identify the study population and among them, 314 randomly selected patients were interviewed. Simple statistics measures were employed for data presentation. The Kruskal-Wallis test and Wilcoxon Rank Sum test, and multiple log-linear regression models were applied to assess the effect of the SSK scheme and identify influencing factors. The regression results were then converted into exponentiated coefficients to facilitate interpretation of the effects on OOP health expenditures.
resultsThe SSK patients incurred significantly lower OOP health expenditures, 3.15 times compared to non-SSK patients seeking inpatient care at SSK facilities, and 3.92 times compared to non-SSK patients at non-SSK facilities. After adjusting for covariates, SSK patients still had significantly reduced OOP health expenditures, 3.71 times lower compared to non-SSK patients at SSK facilities, and 4.36 times lower compared to non-SSK patients at non-SSK facilities. The difference in OOP payment for inpatient care across patient groups was led by direct medical OOP expenditure components. The medicine component was identified as the main driver of the OOP expenditure across patient groups. Residents of town and patients who stayed a single night at hospital experienced significantly reduced OOP expenditures for inpatient care. Among other variables, residents of towns and patients who stayed a single night at the health facility had significantly lower OOP expenditures for inpatient care.
conclusionThe findings suggest that the SSK scheme reduces OOP expenses for beneficiaries and has a spill-over effect on non-beneficiaries. Ensuring service availability and accessibility is crucial for maximizing its benefits. Given its positive impact, scaling up SSK could further reduce OOP nationally and support the government's health financing strategy (2012-2032).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.